Should I buy or sell Cresco Labs stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares. View CRLBF analyst ratings or view top-rated stocks .

What is Cresco Labs' stock price target for 2024?

7 Wall Street research analysts have issued 1 year target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they expect the company's stock price to reach $18.94 in the next twelve months. This suggests a possible upside of 955.4% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts .

How have CRLBF shares performed in 2023?

Cresco Labs' stock was trading at $1.80 at the beginning of the year. Since then, CRLBF stock has decreased by 0.3% and is now trading at $1.7943. View the best growth stocks for 2023 here .

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.04) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.04). The firm earned $190.56 million during the quarter, compared to the consensus estimate of $184.75 million. Cresco Labs had a negative net margin of 43.40% and a negative trailing twelve-month return on equity of 11.72%.

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Cresco Labs Stock Price, News & Analysis (OTCMKTS:CRLBF)

$1.79

+0.09 (+5.45%)

(As of 12/1/2023 08:55 PM ET)

Compare

Today's Range: $1.62
▼
$1.82
50-Day Range: $1.11
▼
$2.13
52-Week Range: $1.00
▼
$4.20

Volume: 581,400 shs
Average Volume: 685,395 shs
Market Capitalization: $620.15 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $18.94

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines SEC Filings Short Interest

Cresco Labs MarketRank™ Stock Analysis

Analyst Rating: Hold
2.29 Rating Score
Upside/Downside: 955.4% Upside
$18.94 Price Target
Short Interest: Healthy
0.48% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.41) to ($0.07) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

3.1

Analyst's Opinion

Consensus Rating
Cresco Labs has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $18.94, Cresco Labs has a forecasted upside of 955.4% from its current price of $1.79.
Amount of Analyst Coverage
Cresco Labs has only been the subject of 1 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
0.48% of the outstanding shares of Cresco Labs have been sold short.
Short Interest Ratio / Days to Cover
Cresco Labs has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cresco Labs has recently decreased by 0.24%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Cresco Labs does not currently pay a dividend.
Dividend Growth
Cresco Labs does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRLBF.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Cresco Labs this week, compared to 2 articles on an average week.
Search Interest
5 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cresco Labs insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.14% of the stock of Cresco Labs is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cresco Labs are expected to grow in the coming year, from ($0.41) to ($0.07) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cresco Labs is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cresco Labs is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cresco Labs has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cresco Labs Stock (OTCMKTS:CRLBF)

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CRLBF Stock News Headlines

December 3, 2023 | americanbankingnews.com

Cresco Labs Inc. (OTCMKTS:CRLBF) Given Average Rating of "Hold" by Brokerages

November 23, 2023 | markets.businessinsider.com

Robust Financial Health and Operational Efficiency: Neal Gilmer Recommends ‘Buy’ for Cresco Labs

December 4, 2023 | Edge On The Street (Ad)

Is This The Most Overlooked Gold Investment Strategy of 2024?

There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.

November 16, 2023 | markets.businessinsider.com

Cresco Labs’ Operational Turnaround and Future Challenges: Assessing Q3 2023 Performance and 2024 Projections

November 16, 2023 | marketwatch.com

Cresco Labs Shares Unwind Yesterday's Gains

November 16, 2023 | realmoney.thestreet.com

Cresco Labs upgraded to Speculative Buy from Market Perform at Cormark

November 15, 2023 | msn.com

Cresco Labs’ stock rises as revenue beats analyst estimate

November 15, 2023 | msn.com

Strong Margins And Cash Flow Drive Cresco's Q3 Performance Despite Revenue Decline

December 4, 2023 | Edge On The Street (Ad)

Is This The Most Overlooked Gold Investment Strategy of 2024?

November 15, 2023 | finance.yahoo.com

Cresco Labs Reports Third Quarter 2023 Financial Results

November 10, 2023 | marketwatch.com

Poll signals more bullish cannabis sentiment as stocks end the week with gains

November 8, 2023 | finance.yahoo.com

Cresco Labs Commends Ohioans on Legalizing Adult-Use Cannabis

November 1, 2023 | finance.yahoo.com

Cresco Labs to Report Third Quarter 2023 Financial Results on November 15, 2023

October 19, 2023 | markets.businessinsider.com

Cresco Labs Unlocks $32M In Non-Dilutive Capital Strengthening Overall Business

October 19, 2023 | finance.yahoo.com

Cresco Labs Unlocks $32 Million in Non-Dilutive Capital

October 18, 2023 | msn.com

Why Cannabis Stocks Like Canopy Growth and Cresco Labs Plummeted Today

October 18, 2023 | msn.com

Where Will Cresco Labs Be in 3 Years?

October 9, 2023 | msn.com

Cresco Labs Has Pulled Back And Could Be A Buy

October 9, 2023 | markets.businessinsider.com

Cresco Labs Launches Six Flavors Of Sublingual Medical Marijuana In Pennsylvania

October 9, 2023 | finance.yahoo.com

Cresco Labs Launches Good News Brand in Pennsylvania with New Sweet Troches

October 5, 2023 | finance.yahoo.com

Cresco Labs Expands Sunnyside in Central Pennsylvania with New Store in Altoona

October 2, 2023 | msn.com

The Cannabist Company Makes Sense To Buy Again

September 21, 2023 | finance.yahoo.com

Cresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower Products

September 16, 2023 | msn.com

Cresco marijuana facility in Wawarsing has yet to create first 75 promised jobs, but maintains a commitment to the project

September 13, 2023 | msn.com

Why Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank Today

September 12, 2023 | markets.businessinsider.com

Cresco Labs Takes On Trulieve As Major Competitor In Florida Where Weed Market Is Poised To Explode

September 12, 2023 | finance.yahoo.com

Cresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store Nationwide

See More Headlines

Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2023
Today: 12/03/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CRLBF
CUSIP: N/A
CIK: 1832928
Web: www.crescolabs.com
Phone: 312-929-0993
Fax: N/A
Employees: 3,200
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $18.94
High Stock Price Target: $34.00
Low Stock Price Target: $2.50
Potential Upside/Downside: +955.4%
Consensus Rating: Hold
Rating Score (0-4): 2.29
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.09)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-212,050,000.00
Net Margins: -43.40%
Pretax Margin: -40.47%
Return on Equity: -11.72%
Return on Assets: -4.12%

Debt

Debt-to-Equity Ratio: 1.50
Current Ratio: 1.16
Quick Ratio: 0.72

Sales & Book Value

Annual Sales: $842.68 million
Price / Sales: 0.74
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.23 per share
Price / Book: 1.46

Miscellaneous

Outstanding Shares: 345,620,000
Free Float: N/A
Market Cap: $620.15 million
Optionable: Not Optionable
Beta: 2.46

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Thomas J. Manning (Age 67)
Executive Chairman of the Board
Comp: $800.05k
Mr. Charles Bachtell (Age 44)
Co-Founder, CEO & Director
Comp: $999.85k
Mr. Robert M. Sampson (Age 48)
Co-Founder & Independent Director
Mr. Dennis M. Olis (Age 60)
Chief Financial Officer
Comp: $622.85k
Mr. Ty Gent (Age 64)
Chief Operating Officer
Ms. Brenna Albert CPA
Senior VP and Controller of Accounting, Treasury & Tax
Mr. Zach Marburger (Age 38)
Chief Information Officer
Jake Graves
Manager of Investor Relations
Mr. John Schetz (Age 45)
General Counsel
Mr. Jason Erkes (Age 52)
Chief Communications Officer

Key Competitors

View All Competitors

CRLBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares.
View CRLBF analyst ratings or view top-rated stocks.
What is Cresco Labs' stock price target for 2024?: 7 Wall Street research analysts have issued 1 year target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they expect the company's stock price to reach $18.94 in the next twelve months. This suggests a possible upside of 955.4% from the stock's current price.
View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts.
How have CRLBF shares performed in 2023?: Cresco Labs' stock was trading at $1.80 at the beginning of the year. Since then, CRLBF stock has decreased by 0.3% and is now trading at $1.7943.
View the best growth stocks for 2023 here.

How were Cresco Labs' earnings last quarter?: Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.04) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.04). The firm earned $190.56 million during the quarter, compared to the consensus estimate of $184.75 million. Cresco Labs had a negative net margin of 43.40% and a negative trailing twelve-month return on equity of 11.72%.
How do I buy shares of Cresco Labs?: Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CRLBF) was last updated on 12/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial